276 related articles for article (PubMed ID: 32848759)
1. NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care.
Woo SD; Luu QQ; Park HS
Front Pharmacol; 2020; 11():1147. PubMed ID: 32848759
[TBL] [Abstract][Full Text] [Related]
2. Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease.
Rhyou HI; Nam YH; Park HS
Allergy Asthma Immunol Res; 2022 Mar; 14(2):153-167. PubMed ID: 35255534
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
4. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim MA; Park HS
Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):1-6. PubMed ID: 24300420
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug hypersensitivity in the Asia-Pacific.
Thong BY
Asia Pac Allergy; 2018 Oct; 8(4):e38. PubMed ID: 30402405
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.
Makowska J; Lewandowska-Polak A; Kowalski ML
Curr Allergy Asthma Rep; 2015 Aug; 15(8):47. PubMed ID: 26149590
[TBL] [Abstract][Full Text] [Related]
7. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
[TBL] [Abstract][Full Text] [Related]
8. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
Park H; Choi Y; Jung CG; Park HS
Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
[TBL] [Abstract][Full Text] [Related]
9. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Parker AR; Ayars AG; Altman MC; Henderson WR
Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
[TBL] [Abstract][Full Text] [Related]
10. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG; Simon HU; Schmitz-Schumann M
Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
[TBL] [Abstract][Full Text] [Related]
11. Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease.
Lee JU; Park JS; Chang HS; Park CS
Allergy Asthma Immunol Res; 2019 Nov; 11(6):779-794. PubMed ID: 31552714
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Tan JHY; Hsu AAL
Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management.
Imam KH; Woessner KM
Pol Arch Intern Med; 2023 Sep; 133(9):. PubMed ID: 37548592
[TBL] [Abstract][Full Text] [Related]
15. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
Celejewska-Wójcik N; Wójcik K; Ignacak-Popiel M; Ćmiel A; Tyrak K; Gielicz A; Kania A; Nastałek P; Sanak M; Mastalerz L
Allergy; 2020 Apr; 75(4):831-840. PubMed ID: 31803947
[TBL] [Abstract][Full Text] [Related]
16. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Lee HY; Ye YM; Kim SH; Ban GY; Kim SC; Kim JH; Shin YS; Park HS
Allergy; 2017 Apr; 72(4):616-626. PubMed ID: 27805264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.
Tuncay G; Damadoglu E; Cihanbeylerden M; Can Bostan O; Kayıkcı H; Özer S; Karakaya G; Kalyoncu AF
J Asthma; 2023 Oct; 60(10):1885-1894. PubMed ID: 36971076
[TBL] [Abstract][Full Text] [Related]
18. An update on the management of aspirin-exacerbated respiratory disease.
Lee JH; Jung CG; Park HS
Expert Rev Respir Med; 2018 Feb; 12(2):137-143. PubMed ID: 29249187
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E
Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
[TBL] [Abstract][Full Text] [Related]
20. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
White AA; Stevenson DD
Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
